Match each patient's clinical presentation and diagnostic findings with the most appropriate targeted antimicrobial regimen.
- A 24-year-old pregnant patient at 10 weeks gestation evaluated in the outpatient clinic for an expanding annular rash with central clearing after an Appalachian trail hike.Oral amoxicillin monotherapy
- A 65-year-old male admitted to the cardiovascular intensive care unit with a mechanical aortic valve, presenting with fever and blood cultures growing methicillin-resistant Staphylococcus aureus (MRSA).Intravenous vancomycin, gentamicin, and rifampin
- A 35-year-old patient with untreated HIV and a CD4 count of 40 cells/mm³ evaluated in the infectious disease clinic for fever, weight loss, and blood cultures yielding Mycobacterium avium complex.Oral clarithromycin and ethambutol
- A 52-year-old female in the emergency department with acute pyelonephritis and septic shock; urine culture reveals Escherichia coli resistant to third-generation cephalosporins and aztreonam.Intravenous meropenem monotherapy
Answer
The correct matches align the pregnant patient with Lyme disease to amoxicillin, the MRSA prosthetic valve endocarditis to vancomycin/gentamicin/rifampin, the disseminated MAC infection to a macrolide/ethambutol, and the ESBL pyelonephritis to a carbapenem.
Each correct pairing directly matches a complex infectious disease scenario with its definitive, guideline-directed antimicrobial regimen, carefully accounting for resistance mechanisms (ESBL), anatomical challenges (prosthetic biofilms), multidrug necessities (mycobacteria), and host safety factors (pregnancy).
Step-by-Step Solution
Key Concept
Selection of targeted antimicrobial therapy must account for pathogen resistance profiles, biofilm presence, and host-specific contraindications.
Estimated Time:2m 0s